In 2011, the FDA became aware of some rare cases of anaplastic large cell lymphoma that were possibly linked to breast implants. Five years later, the World Health Organization identified breast implant-associated anaplastic large cell lymphoma (BIA-ALCL) as a type of T-cell lymphoma. Reporting of the condition was limited, so the FDA and WHO were…